NO20020531D0 - Beta-carbolin medikament produkter - Google Patents

Beta-carbolin medikament produkter

Info

Publication number
NO20020531D0
NO20020531D0 NO20020531A NO20020531A NO20020531D0 NO 20020531 D0 NO20020531 D0 NO 20020531D0 NO 20020531 A NO20020531 A NO 20020531A NO 20020531 A NO20020531 A NO 20020531A NO 20020531 D0 NO20020531 D0 NO 20020531D0
Authority
NO
Norway
Prior art keywords
carbolin
beta
drug products
drug
products
Prior art date
Application number
NO20020531A
Other languages
English (en)
Other versions
NO321602B1 (no
NO20020531L (no
Inventor
Neil R Anderson
Kerry J Hartauer
Martha A Kral
Gregory A Stephenson
Original Assignee
Lilly Icos Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22520112&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20020531(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Icos Llc filed Critical Lilly Icos Llc
Publication of NO20020531D0 publication Critical patent/NO20020531D0/no
Publication of NO20020531L publication Critical patent/NO20020531L/no
Publication of NO321602B1 publication Critical patent/NO321602B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20020531A 1999-08-03 2002-02-01 Faste partikler av en forbindelse som ikke er innleiret i et polymert kopresipitat, metode for fremstilling og anvendelse derav, samt farmasoytisk preparat. NO321602B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14704899P 1999-08-03 1999-08-03
PCT/US2000/020981 WO2001008688A2 (en) 1999-08-03 2000-08-01 Beta-carboline drug products

Publications (3)

Publication Number Publication Date
NO20020531D0 true NO20020531D0 (no) 2002-02-01
NO20020531L NO20020531L (no) 2002-04-03
NO321602B1 NO321602B1 (no) 2006-06-12

Family

ID=22520112

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020531A NO321602B1 (no) 1999-08-03 2002-02-01 Faste partikler av en forbindelse som ikke er innleiret i et polymert kopresipitat, metode for fremstilling og anvendelse derav, samt farmasoytisk preparat.

Country Status (33)

Country Link
EP (1) EP1200092B1 (no)
JP (1) JP4456788B2 (no)
KR (1) KR20020063842A (no)
CN (2) CN1377270A (no)
AR (1) AR033953A1 (no)
AT (1) ATE264680T1 (no)
AU (1) AU773666B2 (no)
BR (1) BR0012901A (no)
CA (1) CA2380087C (no)
CO (1) CO5200849A1 (no)
CZ (1) CZ300151B6 (no)
DE (1) DE60010089T2 (no)
DK (1) DK1200092T3 (no)
DZ (1) DZ3180A1 (no)
EA (1) EA004302B9 (no)
ES (1) ES2220506T3 (no)
HK (1) HK1044278B (no)
HR (1) HRP20020091B1 (no)
HU (1) HU229443B1 (no)
IL (1) IL147642A0 (no)
MX (1) MXPA02001197A (no)
MY (1) MY125428A (no)
NO (1) NO321602B1 (no)
NZ (1) NZ516613A (no)
PE (1) PE20010480A1 (no)
PL (1) PL199469B1 (no)
PT (1) PT1200092E (no)
SK (1) SK286365B6 (no)
SV (1) SV2002000137A (no)
TW (1) TWI235658B (no)
UA (1) UA71629C2 (no)
WO (1) WO2001008688A2 (no)
ZA (1) ZA200200825B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60039357D1 (de) * 1999-08-03 2008-08-14 Lilly Icos Llc Pharmazeutische zusammensetzung enthaltend tadalafil
WO2006049986A1 (en) * 2004-10-28 2006-05-11 Dr. Reddy's Laboratories Ltd. Polymorphic forms of tadalafil
CA2627693A1 (en) * 2006-01-05 2007-07-19 Teva Pharmaceutical Industries Ltd. Wet granulation pharmaceutical compositions of aripiprazole
DE102007028869A1 (de) 2007-06-22 2008-12-24 Ratiopharm Gmbh Verfahren zur Herstellung eines Arzneimittels enthaltend Tadalafil
MD4009C2 (ro) * 2008-07-15 2010-08-31 Институт Химии Академии Наук Молдовы Utilizarea 1-metil-4-(N-metilaminobutil-4)-β-carbolinei în calitate de remediu antituberculos
DE102009033396A1 (de) 2009-07-16 2011-01-20 Ratiopharm Gmbh Wässrige Lösung und gelatinierte Zusammensetzung umfassend einen Phosphodiesterase-5-Inhibitor sowie diesbezügliche Verfahren und Verwendung
DE102009035211A1 (de) 2009-07-29 2011-02-17 Ratiopharm Gmbh Copräzipitate umfassend einen Phosphodiesterase-5-Inhibitor (PDE-5-Inhibitor) und einen pharmazeutisch verträglichen Trägerstoff, ihre Herstellung und Verwendung
WO2012085927A2 (en) * 2010-12-02 2012-06-28 Mylan Laboratories, Limited Tadalafil compositions
WO2012095151A1 (en) 2010-12-23 2012-07-19 Zaklady Farmaceutyczne Polpharma Sa Solid pharmaceutical dosage forms comprising tadalafil and methods of preparation thereof
WO2012107541A1 (en) 2011-02-10 2012-08-16 Synthon Bv Pharmaceutical composition comprising tadalafil and a cyclodextrin
WO2012107090A1 (en) 2011-02-10 2012-08-16 Synthon Bv Granulated composition comprising tadalafil and a disintegrant
WO2012107092A1 (en) 2011-02-10 2012-08-16 Synthon Bv Pharmaceutical composition comprising tadalafil and a cyclodextrin
JP5930686B2 (ja) * 2011-12-07 2016-06-08 株式会社トクヤマ 溶解性および安定性の向上した難溶性医薬品原体及びその製造方法
CN104205390B (zh) 2012-03-15 2017-08-25 默克专利有限公司 电子器件
WO2014003678A1 (en) * 2012-06-28 2014-01-03 Xspray Microparticles Ab Pharmaceutical compositions comprising ambrisentan and solid dispersion particles containing tadalafil
WO2014003677A1 (en) * 2012-06-28 2014-01-03 Xspray Microparticles Ab Pharmaceutical compositions comprising solid dispersion particles containing tadalafil
CN105310984A (zh) * 2014-06-10 2016-02-10 合肥贝霓医药科技有限公司 一种pde5抑制剂的超微粉体及其制备方法
JP6445559B2 (ja) * 2014-06-24 2018-12-26 ウーシン ラボタチ カンパニー, リミテッドWooshin Labottach Co., Ltd. タダラフィルを含む口腔内崩壊フィルム製剤およびその製造方法
EP3172207B1 (en) 2014-07-23 2019-03-06 KRKA, d.d., Novo mesto A process for the preparation of cgmp-phosphodiesterase inhibitor and oral pharmaceutical formulation comprising tadalafil co-precipitates
JP2016106139A (ja) * 2016-03-07 2016-06-16 株式会社トクヤマ 溶解性および安定性の向上した難溶性医薬品原体及びその製造方法
SG11202006080SA (en) * 2017-12-26 2020-07-29 Ftf Pharma Private Ltd Liquid oral formulations for pde v inhibitors
ES2824818T3 (es) 2018-01-10 2021-05-13 Gap S A Cápsulas de gelatina blanda que comprenden una suspensión de tadalafilo
CN110638770B (zh) * 2019-10-25 2022-04-05 株洲千金药业股份有限公司 他达拉非片剂的制备方法及以该方法制得的片剂
WO2023227185A1 (en) 2022-05-27 2023-11-30 Rontis Hellas S.A. Improved pharmaceutical composition containing tadalafil and nanomilling process for the preparation thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618845A (en) * 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
GB9511220D0 (en) * 1995-06-02 1995-07-26 Glaxo Group Ltd Solid dispersions

Also Published As

Publication number Publication date
HRP20020091A2 (en) 2004-02-29
AU6508400A (en) 2001-02-19
DK1200092T3 (da) 2004-08-16
EA004302B9 (ru) 2019-01-31
SV2002000137A (es) 2002-06-07
ES2220506T3 (es) 2004-12-16
IL147642A0 (en) 2002-08-14
PE20010480A1 (es) 2001-05-26
JP2003505510A (ja) 2003-02-12
MY125428A (en) 2006-07-31
PL353268A1 (en) 2003-11-03
SK286365B6 (sk) 2008-08-05
PT1200092E (pt) 2004-07-30
SK1722002A3 (en) 2002-05-09
ZA200200825B (en) 2003-04-30
HU229443B1 (en) 2013-12-30
DE60010089D1 (de) 2004-05-27
WO2001008688A3 (en) 2001-08-16
DZ3180A1 (fr) 2001-02-08
BR0012901A (pt) 2002-04-16
WO2001008688A2 (en) 2001-02-08
NO321602B1 (no) 2006-06-12
EP1200092B1 (en) 2004-04-21
KR20020063842A (ko) 2002-08-05
CZ2002387A3 (cs) 2002-10-16
HK1044278A1 (en) 2002-10-18
EP1200092A2 (en) 2002-05-02
HRP20020091B1 (en) 2006-02-28
UA71629C2 (en) 2004-12-15
EA200200119A1 (ru) 2002-06-27
TWI235658B (en) 2005-07-11
CO5200849A1 (es) 2002-09-27
CZ300151B6 (cs) 2009-02-25
ATE264680T1 (de) 2004-05-15
AR033953A1 (es) 2004-01-21
JP4456788B2 (ja) 2010-04-28
NZ516613A (en) 2003-08-29
CN1377270A (zh) 2002-10-30
HUP0202781A2 (hu) 2002-12-28
MXPA02001197A (es) 2003-02-12
NO20020531L (no) 2002-04-03
EA004302B1 (ru) 2004-02-26
HUP0202781A3 (en) 2003-10-28
CA2380087A1 (en) 2001-02-08
HK1044278B (zh) 2004-10-08
PL199469B1 (pl) 2008-09-30
DE60010089T2 (de) 2004-10-14
CN101134019A (zh) 2008-03-05
CA2380087C (en) 2007-05-01
AU773666B2 (en) 2004-06-03

Similar Documents

Publication Publication Date Title
NO20020531D0 (no) Beta-carbolin medikament produkter
DE60040552D1 (de) Medikamentspender
EE200200361A (et) Hüdrogeeli-juhitav ravimi doseerimise vahend
DE60016271D1 (de) Medikamentenzuführvorrichtung
ID23874A (id) Obat
DE60011853D1 (de) Injektionsspritze
NO20020235D0 (no) Medisinsk anordning
NO20014490L (no) Medisinske blandinger
FI4823U1 (fi) Muunnetulla tavalla vapauttava lääkeformulaatio
NO20020086D0 (no) Smaksmaskerte farmasöytiske flytende formuleringer
DE50001455D1 (de) Blisterverpackung
PT1210085E (pt) Solucoes farmaceuticas de levosimendano
NO20022606L (no) Farmasöytiske kombinasjoner
DK1275397T3 (da) Lægemiddel til lokal anvendelse
NO20005179D0 (no) Medikament behandling
NO20014926D0 (no) Farmasöytiske forbindelser
IS6163A (is) Lyfjakomplex
AR025867A1 (es) Formulacion portasdora farmaceutica
DE59905747D1 (de) Blisterpackung
ATA173599A (de) Pharmazeutisches produkt
UA2855S (uk) Таблетка фармацевтична
DK199900429U1 (da) Aktive produkter med værdifulde egenskaber
FIU990361U0 (fi) Hammaslankatuote
FIU990118U0 (fi) Hammaslankatuote
FI990981A0 (fi) Naltreksonivalmiste

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ICOS CORP, UG

CREP Change of representative

Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA